5-HT4 receptor ligand RS67333 modulates striatal acetylcholine and dopamine release via inhibition of acetylcholinesterase
Qinbo Qiao, Wenhui Wu, Stephanie Jane Cragg
This study shows RS67333 modulates striatal dopamine and acetylcholine release by inhibiting acetylcholinesterase, not through 5-HT4R activation, and highlights the potential of AChE inhibitors for treating ACh/DA disorders.
ACS Chemical Neuroscience · Jul 20, 2026Peer-reviewedNeuroscience